Back to search results

A Study of LY4213663 in Healthy Participants and Participants With Rheumatoid Arthritis

Abroad (travel likely)RecruitingPHASE1

Conditions

Rheumatoid Arthritis (RA)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

  • Pinnacle Research Group, LLC, Anniston, Alabama, United States

    Study coordinator · 256-236-0055, ext 101
    Contact: Principal Investigator (Vishala Chindalore)

  • Arizona Research Center, Phoenix, Arizona, United States

    Study coordinator · 602-773-3020
    Contact: Principal Investigator (Louise Taber)

  • Clinical Research of West Florida, Inc. (Clearwater), Clearwater, Florida, United States

    Study coordinator · 727-466-0078
    Contact: Principal Investigator (Robert Levin)

  • GNP Research at Mark Jaffe, MD, Cooper City, Florida, United States

    Study coordinator · 754-248-3589
    Contact: Principal Investigator (Mark Jaffe)

  • Fortrea Clinical Research Unit, Daytona Beach, Florida, United States

    Study coordinator · 866-429-3700
    Contact: Principal Investigator (Sharrell Cooper)

  • AGA Clinical Trials, Hialeah, Florida, United States

    Study coordinator · 704-526-6864
    Contact: Principal Investigator (WILSON CUEVA)

  • Advanced Pharma CR, LLC, Miami, Florida, United States

    Study coordinator · 305-220-2727, Ext 802
    Contact: Principal Investigator (Simon Abelson)

  • Floridian Clinical Research, Miami Lakes, Florida, United States

    Study coordinator · 305-330-9977
    Contact: Principal Investigator (Christopher Mesa)

  • Oasis Clinical Research, Las Vegas, Nevada, United States

    Study coordinator · 702-832-1369
    Contact: Principal Investigator (Stephen Tam)

  • Universitätsklinikum Charité, Berlin, Germany

    Study coordinator · +49 30 450 539 200
    Contact: Principal Investigator (Stanislav Ignatenko)
Study leads

  • Call 1-877-CTLILLY (1-877-285-4559) or 1-317-615-4559 Mon - Fri 8 AM - 8 PM Eastern time (UTC/GMT - 5 hours, EST)

    Study Director

    Eli Lilly and Company

View source on ClinicalTrials.gov(opens in a new tab)